Skip to main content
Log in

Antineoplastics

Thyroid disorders and lack of efficacy: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Someya M, et al. Combined chemoradiotherapy and programmed cell death-ligand 1 blockade leads to changes in the circulating T-cell receptor repertoire of patients with non-small-cell lung cancer. Cancer Science 113: 4394-4400, No. 12, Dec 2022. Available from: URL: http://onlinelibrary.wiley.com/journal/10.1111/1349-7006

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1942, 43 (2023). https://doi.org/10.1007/s40278-023-32652-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-32652-3

Navigation